Clinical Trial Update: Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating steroids and unfractionated heparin in critically ill COVID-19 pneumonia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulopathy
• Pneumonia Viral
• Sars-cov Infection

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)
• steroids

Snippet

Sponsor: Massimo Girardis | Conditions: Covid19, SARS-CoV Infection | Phase 3 | Status: UNKNOWN